These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 808560

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 4. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT, Austen KF, Ruddy S.
    Rheumatology; 1975 Jul; 6():2-16. PubMed ID: 1105744
    [No Abstract] [Full Text] [Related]

  • 5. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ.
    J Immunol; 1986 May 01; 136(9):3378-83. PubMed ID: 3485688
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H, Good RA, Day NK.
    Clin Nephrol; 1975 May 01; 3(4):139-47. PubMed ID: 1149337
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Complement activation in acute coronary syndromes.
    Iltumur K, Karabulut A, Toprak G, Toprak N.
    APMIS; 2005 Mar 01; 113(3):167-74. PubMed ID: 15799759
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.
    Cancer Res; 1993 Feb 01; 53(3):592-9. PubMed ID: 8425193
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activation of the alternative pathway of the complement system by radiographic contrast media.
    Arroyave CM, Bhat KN, Crown R.
    J Immunol; 1976 Nov 01; 117(5 Pt.2):1866-9. PubMed ID: 993582
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.
    Berman S, Gewurz H, Mold C.
    J Immunol; 1986 Feb 15; 136(4):1354-9. PubMed ID: 3944459
    [Abstract] [Full Text] [Related]

  • 18. Serotherapy of primary rat mammary carcinoma: inhibition by ethylenedinitrilotetraacetic acid but not by [ethylenebis(oxyethylenenitrilo)]tetraacetic acid.
    Nakanishi K, Zbar B, Borsos T, Glenn G.
    Cancer Res; 1986 Aug 15; 46(8):3886-90. PubMed ID: 3089581
    [Abstract] [Full Text] [Related]

  • 19. Structure and activation of the early components of complement.
    Porter RR.
    Fed Proc; 1977 Aug 15; 36(9):2191-6. PubMed ID: 328305
    [No Abstract] [Full Text] [Related]

  • 20. Nonimmunologic complement activation in normal human serum induced by radiographic contrast media.
    Kolb WP, Lang JH, Lasser EC.
    J Immunol; 1978 Oct 15; 121(4):1232-8. PubMed ID: 100552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.